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Porcine endogenous retroviruses (PERVs) infect human cells in vitro and therefore represent a risk for xenotransplantation.
However, first clinical transplantations of pig cells into humans or ex vivo perfusions did not result in transmission of PERVs.
On the other hand, recent experiments with SCID mice demonstrated infections with PERV in vivo. In order to define and
characterize human target cells, we studied numerous primary human cells and cell lines. Infection with PERVs was shown
for human peripheral blood mononuclear cells, primary endothelial cells, and primary aortic smooth muscle cells as well as
lymphocytic, monocytic, and epithelial cell lines. © 2001 Academic Press
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sIntroduction. Progress in transplantation medicine and
the shortage of human organs is the driving force in the
search of alternative methods to allotransplantation. One
of the most promising applications is xenotransplanta-
tion. Pigs are favored as potential donors of cells, tis-
sues, and organs in comparison with nonhuman pri-
mates because of a lower contamination with micro-
organisms, the availability of transgenic animals, and
lower costs (1). Since most micro-organisms of the pig
with the potential to cause a zoonosis can be eliminated
by specified pathogen-free containment, the most pro-
nounced risk comes from unknown organisms and from
porcine endogenous retroviruses (PERVs) (4). Different
types of PERV are present in the genome of all pig
strains and at least PERV-A and PERV-B are able to infect
human cells in vitro (6, 8, 10, 11, 14, 16, 21, 22). Investi-
ations of human recipients who had short-term contact
ith porcine cells or tissues and of nonhuman primates
ith pig cell or organ transplantation showed no evi-
ence of PERV infection (9, 12, 15, 18, 20). In contrast to
hese results infection of SCID mice with PERV after
orcine islet xenotransplantation has been recently de-
cribed (3, 5), showing that trans-species transmission of
ERV in vivo is possible. In order to evaluate the poten-
ial risk posed by PERVs during the future clinical use of
orcine xenografts, understanding the mechanism of vi-
us transmission and the nature and range of human
arget cells is essential. We show that all primary human
ells and cell lines tested could be infected (and exceptl
t
1 To whom reprint requests should be addressed. Fax: 149-30-4547-
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177one, all of them produce virus particles), indicating that a
wide range of human cells carry the still unknown re-
ceptors for PERVs.
Results and Discussion. PERV-NIH, a PERV-A/C re-
combinant produced by human 293 cells (kindly provided
by C. Wilson, FDA, Washington; 23) was serially pas-
saged on the human kidney cell line 293. After each
passage the virus titer increased and the time to detect
infection decreased as has also been shown for PERV
from pig PK-15 cells, passaged on human 293 cells (16).
assage 5 of PERV-NIH was used for the infection ex-
eriments with all human cells and cell lines listed in
able 1. Infection was evaluated by PCR using primers
pecific for PERV gag, env, and pol. Positive PCR ampli-
ication was seen in all cases starting with day 10 postin-
ection showing the presence of proviral DNA in infected
ells (Table 1, Fig. 1). In addition, cell-free supernatants
rom infected cells were screened for RT activity for the
etection of productive infection. The human kidney cell
ine 293, primary pulmonary artery endothelial cells
HPAEC), primary aortic endothelial cells (HAEC), and
rimary human peripheral blood mononuclear cells (PB-
Cs) showed RT activity already 1 week postinfection.
he human lymphocytic cell lines C8166, THP-1, and
IL2.NS.6TG were positive for type C retroviral-specific
T activity only 3–5 weeks postinfection. However, the
rimary coronary artery smooth muscle cells (HCASMC)
howed, despite detection of provirus, no RT activity
uring the time of cultivation. Because of the limited life
pan of these primary cells they could not be studiedater on. To investigate the productive infection of the
arget cells in more detail, virus was pelleted from cell
0042-6822/01 $35.00
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178 RAPID COMMUNICATIONculture supernatants and viral RNA was isolated. In a
RT-PCR using primers specific for PERV pol, RNA from
viral particles derived from PERV-infected 293, C8166,
THP-1, and WIL2.NS.6TG cells showed positive ampli-
cons (Table 1, Fig. 2). In addition, the human lymphocytic
cell line C8166, the monocytic cell line THP-1, and the
spleen cell line WIL2.NS.6TG as well as the human
kidney cell line 293 were also tested for the expression
of viral proteins by an immunoperoxidase assay (IPA)
using a PERV-specific antiserum against the recombi-
nant envelope protein rp15E. In all cases cells showed
expression of p15E indicating, apart from integration of
proviral DNA, the expression of viral proteins and sup-
porting production of virus particles. The ability to infect
the chosen primary human cells as well as human PB-
MCs, lymphocytic cells, and monocytic cells productively
T
Infection
Cells Tissue
PBMC Blood
C8166 T cell line
THP-1 Monocyte cell line
WIL2.NS.6TG Spleen cell line
HPAEC Primary pulmonary artery endothelial cells
AEC Primary aortic endothelial cells
CASMC Primary coronary artery smooth muscle cells
93 Kidney cell line
Note. n.t., not tested.
a Mean 6 SD of triplicate measurement in one experiment. Some e
FIG. 1. Detection of PERV in infected human cells by PCR. Primers
pecific for (A) PERV pol (expected amplicon 817 bp) and (B) human
b-actin (expected amplicon 528 bp) were used: lanes 1, uninfected
HPAEC; 2, infected HPAEC; 3, uninfected HAEC; 4, infected HAEC; 5,
uninfected HCASMC; 6, infected HCASMC; 7, uninfected C8166; 8,
infected C8166; 9, uninfected THP-1; 10, infected THP-1; 11, uninfected
WIL2.NS.6TG; 12, infected WIL2.NS.6TG; 13, uninfected PBMC; 14,
infected PBMC; 15, uninfected 293; 16, infected 293; 17, 293-NIH/
passage 5; M, 100 bp ladder.with PERV has severe implications since circulating im-
mune cells come into close contact with the xenotrans-
plant and may transmit the virus to other human cell
compartments. In that context, productive infection of
C8166 cells with virus produced by PERV-infected C8166
cells (10 6 2 mU RT activity/ml) was shown. Virus pro-
duction was demonstrated by measuring RT activity in
the supernatant (9 6 1 mU RT activity/ml), indicating
transmission and replication competence of PERV on
this human T cell line. But replication has been to a
smaller extent in comparison to uninfected human 293
cells inoculated with the same amount of PERV from
infected C8166 cells in parallel. Similar differences were
observed with PERV produced from the productively in-
fected mink lung cell line Mv1Lu. Virus produced from
PERV-infected Mv1Lu cells more easily infected 293 cells
in comparison to Mv1Lu cells (V. Specke et al., in prep-
aration). It is noteworthy to stress that the human kidney
cell line 293 showed the highest sensitivity for PERV
infection among all human cells tested here (Table 1) and
the amount of virus produced by 293 cells is much higher
in comparison with pig kidney cell lines producing PERV
an Cells
Detection of PERV
PCR mU RT/mla RT-PCR IPA
1 12 6 3 1 n.t.
1 10 6 2 1 1
1 19 6 2 1 1
1 37 6 5 1 1
1 15 6 1 n.t. n.t.
1 17 6 3 n.t. n.t.
1 — n.t. n.t.
1 530 6 12 1 1
ents were performed up to 10 times showing similar data.
FIG. 2. One-step RT-PCR with RNA from pelleted virus produced by
infected human cells using primers specific for PERV pol (expectedABLE 1
of Humamplicon 817 bp): lanes 1, 293; 2, C8166; 3, THP-1; 4, WIL2.NS.6TG; 5,
PBMC; 6, 293-NIH/passage 5; M, 100 bp ladder.
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179RAPID COMMUNICATIONcontinuously (Table 2). In addition, all (except one) hu-
man primary cells and cell lines tested released PERV on
higher levels than primary pig PBMCs after mitogen
stimulation (Tables 1 and 2). This suggests that PERVs
which are released from porcine cells at a very low titer
are able to increase their replication competence after
infection of human cells.
Taken together, our data and recent publications on
the host range of PERV (6, 7, 10, 11, 14, 16, 21, 22) show
that human cells are very permissive for PERVs. Further-
more, we showed for the first time (i) productive infection
of human PBMCs; (ii) infection of primary muscle cells;
(iii) productive infection of human lymphocytic, mono-
cytic, and spleen cell lines with PERV; and (iv) productive
transmission of PERV produced from the human T cell
line C8166 to uninfected C8166 cells. These data strongly
emphasize the need for further research in the field of
PERV transmission before commencing with xenotrans-
plantation in humans. For that reason we started, in
addition to the attempts to establish a small animal
model (16), an infection study with nonhuman primates to
obtain further information on the infection potential of
PERV in vivo.
Materials and Methods. Virus production. PERV-NIH
(kindly provided by C. Wilson, FDA, Washington, DC;
PERV-NIH, 3rd passage) (23) was passaged on human
93 kidney cells and passage 5 was used for infections
hat were carried out using cell-free cell culture super-
atants. For comparison, PERV produced by the pig kid-
ey cell line PK-15 (ATCC CCL 33, U.S.A.), and PERV
eleased from PBMCs isolated from the blood of healthy
utbred Yucatan micropigs (Charles River, Germany) as
escribed (19), cultured in RPMI 1640 with 10% FCS,
timulated with 72 mg/ml phytohemagglutinin (Abbott
urex, Germany) for 5 days in the presence of 100 IU/ml
L-2 (EuroCetus GmbH, Germany) were studied.
Cells Used for Infection. The human T cell line C8166
ECACC, 88051601), the human monocytic cell line THP-1
ATCC, TIB-202), the uninfected human kidney cell line
93 (also kindly provided from C. Wilson, FDA, Washing-
TABLE 2
Comparison of PERV Production by Porcine and Human Cells
Species Cell line mU RT/mla
Pig PBMCb 5 6 2
PK-15 70 6 10
Human 293-NIH/5 530 6 12
a Mean 6 SD of triplicate measurement in one experiment. Some
experiments were performed up to 10 times showing similar data.
b Mitogen stimulated.on, DC), the human spleen cell line WIL2.NS.6TG
ECACC, 93031001), human primary pulmonary arteryndothelial cells, human aortic endothelial cells, and
uman coronary artery smooth muscle cells (all three
ascade Biologics, Inc., Portland, OR) were cultured ac-
ording to the directions of the contributors. Human
BMCs were isolated from healthy blood donors as
escribed elsewhere (19) and grown in RPMI 1640 with
0% FCS, 2 mM glutamine, 100 U/ml penicillin, and 100
mg/ml streptomycin (Life Technologies GmbH, Germany).
All cells were inoculated with a standard virus dose of
1 3 105 TCID50/ml for 24 h in the presence of 8 mg/ml
Polybrene (Sigma, Deisenhofen, Germany).
PCR. PCR was performed as described previously (16)
using primers specific for PERV gag (forward, 59-GCG
ACC CAC GCA GTT GCA TA; reverse, 59-CAG TTC CTT
GCC CAG TGT CCT T; and forward, 59-TGA TCT AGT
GAG AGA GGC AGA G; reverse, 59-CGC ACA CTG GTC
CTT GTC G (12)), env of PERV-A (forward, 59-TGG AAA
GAT TGG CAA CAG CG; reverse, 59-AGT GAT GTT AGG
CTC AGT GG (6)), and env of PERV-B (forward, 59-TTC
TCC TTT GTC AAT TCC GG; reverse, 59-TAC TTT ATC
GGG TCC CAC TG (6)) as well as for pol of PERV (for-
ward, 59-TTG ACT TGG GAG TGG GAC GGG TAA C;
reverse, 59-GAG GGT CAC CTG AGG GTG TTG (2)).
Amplification was carried out using standard PCR con-
ditions on a Biozym cycler (Biozym Diagnostic, Olden-
dorf, Germany): 1 initial cycle of 10 min denaturation at
95°C; 35 cycles of 1 min denaturation at 95°C, 1 min
annealing at 58°C, 1 min elongation at 72°C; and 1 final
cycle of 7 min elongation at 72°C.
RT-PCR. For RT-PCR viral RNA from supernatants of
cultured cells was isolated. Cells were removed from
supernatants by centrifugation at 200 g for 10 min. There-
after cell debris were removed by centrifugation at 3500
g for 10 min and an additional centrifugation step at
10,000 rpm (SW 28; Beckmann, Germany) for 10 min.
Virus was pelleted by ultracentrifugation (28,000 rpm for
3 h, SW 28) and viral RNA was isolated using the viral
RNA isolation kit from Qiagen GmbH (Germany). RNA
was reverse transcribed using a one-step RT-PCR kit
(Life Technologies GmbH) and cDNA was screened for
detection of PERV using PCR carried out with PERV-
specific primers as described above.
RT Assay. For detection of productive infection of tar-
get cells with PERV a commercial reverse transcriptase
assay (Cavidi Tech, Uppsala, Sweden) was used.
Immune Peroxidase Assay. Virus protein expression
was analyzed using an IPA performed as described (17).
Briefly, cells were trypsinized and seeded in a six-well
plate (1 3 105 cells/well) coated with poly-D-lysine
(Greiner, Frickenhausen, Germany). After incubation for
4 h at 37°C, 5% CO2, and 98% humidity, cells were
washed twice with PBS and fixed with methanol over
night at 220°C. Cells were treated with 2% fat-free milk
powder (Marvel, UK) in PBS for 1 h to block nonspecific
180 RAPID COMMUNICATIONantibody binding. After blocking, the cells were incu-
bated for 1 h with PERV-specific antiserum against re-
combinant p15E (diluted 1:100 in blocking solution). After
four washes with PBS, protein G labeled with horserad-
ish peroxidase (1:5000 in blocking solution) was added
to the cells. After 1 h incubation cells were washed again
four times with PBS and the substrate 3-amino-9-ethyl-
carbazole (Sigma) was added.
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